US 8901309
Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8901309 (Fused triazoles for the treatment or prophylaxis of mild cognitive impairment) held by Takeda Pharmaceutical Company Limited expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P43/00